1
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Cystine / metabolism...

2
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Glycated Hemoglobin A / metabolism...

3
Published 2017
CADTH
...), is an autosomal recessive inborn error of metabolism caused by mutations in the gene encoding PAH, the enzyme...

4
Published 2017
CADTH
...), is an autosomal recessive inborn error of metabolism caused by mutations in the gene encoding PAH, the enzyme...

5
Published 2018
CADTH

6
Published 2018
Canadian Agency for Drugs and Technologies in Health

7
Published 2018
CADTH

8
by Tran, Khai, Picheca, Lory
Published 2017
Canadian Agency for Drugs and Technologies in Health
... to or production of insulin, leading to the abnormal metabolism of sugar and increase in blood sugar level.1 Over...

9
Published 2018
Canadian Agency for Drugs and Technologies in Health

11
by Tran, Khai, Picheca, Lory
Published 2017
Canadian Agency for Drugs and Technologies in Health
... to or production of insulin, leading to the abnormal metabolism of sugar and increase in blood sugar level.1 Over...

12
Published 2017
Canadian Agency for Drugs and Technologies in Health
... metabolism, which can be life-threatening and result in permanent neurological damage if left untreated....

13
Published 2017
Canadian Agency for Drugs and Technologies in Health

15
Published 2014
Canadian Agency for Drugs and Technologies in Health
... desired changes without detrimental impact on vitamins and bone metabolism, and to determine...

16
Published 2014
Canadian Agency for Drugs and Technologies in Health
... desired changes without detrimental impact on vitamins and bone metabolism, and to determine...

17
Published 2017
Canadian Agency for Drugs and Technologies in Health
...1) who are cytochrome P450 2D6 (CYP2D6) poor metabolizers, intermediate metabolizers, or extensive...

18
Published 2017
Canadian Agency for Drugs and Technologies in Health
...1) who are cytochrome P450 2D6 (CYP2D6) poor metabolizers, intermediate metabolizers, or extensive...

19
Published 2017
Canadian Agency for Drugs and Technologies in Health
... disease type 1 (GD1) who are poor metabolizers, intermediate metabolizers, or extensive metabolizers...

20
Published 2019
CADTH
...Diabetes mellitus is a metabolic disease that is characterized by persistent elevations in blood...